Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ISRCTN84791030) titled 'ELITE: Deep profiling and algorithmic polytherapy to map individual response in healthy aging' on Sept. 28.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial
Masking: Open (masking not used)
Control: Active
Assignment: Parallel
Purpose: Treatment
Primary Sponsor: Sheba Medical Center
Condition:
Healthy aging and multidomain functional health
Other
Intervention:
ELITE was a randomized, open-label, two-active-arm Phase IIa pilot conducted at Sheba Medical Center, Ramat Gan, Israel. Thirty-one adults aged 50-80 years without diabetes were randomized 1:1 after baseline procedures u...